Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1981 Nov;34(11):1285–1294. doi: 10.1136/jcp.34.11.1285

Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.

I S Parkinson, M K Ward, D N Kerr
PMCID: PMC494487  PMID: 7320226

Full text

PDF
1290

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackrill P., Barron J., Whiteley S., Horn A. C., Ralston A. J. A new approach to the early detection of dialysis encephalopathy. Proc Eur Dial Transplant Assoc. 1979;16:659–660. [PubMed] [Google Scholar]
  2. Ackrill P., Ralston A. J., Day J. P., Hodge K. C. Successful removal of aluminium from patient with dialysis encephalopathy. Lancet. 1980 Sep 27;2(8196):692–693. doi: 10.1016/s0140-6736(80)92728-2. [DOI] [PubMed] [Google Scholar]
  3. Alfrey A. C. Dialysis encephalopathy syndrome. Annu Rev Med. 1978;29:93–98. doi: 10.1146/annurev.me.29.020178.000521. [DOI] [PubMed] [Google Scholar]
  4. Alfrey A. C., LeGendre G. R., Kaehny W. D. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med. 1976 Jan 22;294(4):184–188. doi: 10.1056/NEJM197601222940402. [DOI] [PubMed] [Google Scholar]
  5. Alfrey A. C., Mishell J. M., Burks J., Contiguglia S. R., Rudolph H., Lewin E., Holmes J. H. Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Trans Am Soc Artif Intern Organs. 1972;18(0):257-61, 266-7. doi: 10.1097/00002480-197201000-00064. [DOI] [PubMed] [Google Scholar]
  6. Arieff A. I., Cooper J. D., Armstrong D., Lazarowitz V. C. Dementia, renal failure, and brain aluminum. Ann Intern Med. 1979 May;90(5):741–747. doi: 10.7326/0003-4819-90-5-741. [DOI] [PubMed] [Google Scholar]
  7. Berlyne G. M., Ben-Ari J., Pest D., Weinberger J., Stern M., Levine R., Gilmore G. R. Hyperaluminaemia from aluminum resins in renal failure. Lancet. 1970 Sep 5;2(7671):494–496. doi: 10.1016/s0140-6736(70)90113-3. [DOI] [PubMed] [Google Scholar]
  8. Boukari M., Rottembourg J., Jaudon M. C., Clavel J. P., Legrain M., Galli A. Influence de la prise prolongée de gels d'alumine sur les taux sériques d'aluminium chez les patients atteints d'insuffisance rénale chronique. Nouv Presse Med. 1978 Jan 14;7(2):85–88. [PubMed] [Google Scholar]
  9. Branger B., Ramperez P., Marigliano N., Mion H., Shaldon S., Mion C. Aluminium transfer in bicarbonate dialysis using a sorbent regenerative system: an in vitro study. Proc Eur Dial Transplant Assoc. 1980;17:213–218. [PubMed] [Google Scholar]
  10. Buge A., Poisson M., Masson S., Bleibel J. M., Mashaly R., Jaudon M. C., Lafforgue B., Lebkiri B., Raymond P. Encéphalopathie réversible des dialysés après arrêt de l'apport d'aluminium. 6 cas. Nouv Presse Med. 1979 Sep 10;8(34):2729–2733. [PubMed] [Google Scholar]
  11. Burks J. S., Alfrey A. C., Huddlestone J., Norenberg M. D., Lewin E. A fatal encephalopathy in chronic haemodialysis patients. Lancet. 1976 Apr 10;1(7963):764–768. doi: 10.1016/s0140-6736(76)91608-1. [DOI] [PubMed] [Google Scholar]
  12. Cartier F., Allain P., Gary J., Chatel M., Menault F., Pecker S. Encéphalopathie myoclonique progressive des dialysés. Rôle de l'eau utilisée pour l'hémodialyse. Nouv Presse Med. 1978 Jan 14;7(2):97–102. [PubMed] [Google Scholar]
  13. Chokroverty S., Bruetman M. E., Berger V., Reyes M. G. Progressive dialytic encephalopathy. J Neurol Neurosurg Psychiatry. 1976 May;39(5):411–419. doi: 10.1136/jnnp.39.5.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Chui H. C., Damasio A. R. Progressive dialysis encephalopathy ("dialysis dementia"). J Neurol. 1980 Jan;222(3):145–157. doi: 10.1007/BF00313113. [DOI] [PubMed] [Google Scholar]
  15. Clarkson E. M., Luck V. A., Hynson W. V., Bailey R. R., Eastwood J. B., Woodhead J. S., Clements V. R., O'Riordan J. L., De Wardener H. E. The effect of aluminium hydroxide on calcium, phosphorus and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure. Clin Sci. 1972 Oct;43(4):519–531. doi: 10.1042/cs0430519. [DOI] [PubMed] [Google Scholar]
  16. Drüeke T. Dialysis osteomalacia and aluminum intoxication. Nephron. 1980;26(5):207–210. doi: 10.1159/000181985. [DOI] [PubMed] [Google Scholar]
  17. Dunea G., Mahurkar S. D., Mamdani B., Smith E. C. Role of aluminum in dialysis dementia. Ann Intern Med. 1978 Apr;88(4):502–504. doi: 10.7326/0003-4819-88-4-502. [DOI] [PubMed] [Google Scholar]
  18. Elliott H. L., Dryburgh F., Fell G. S., Sabet S., Macdougall A. I. Aluminium toxicity during regular haemodialysis. Br Med J. 1978 Apr 29;1(6120):1101–1103. doi: 10.1136/bmj.1.6120.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Elliott H. L., Macdougall A. I. Aluminium studies in dialysis encephalopathy. Proc Eur Dial Transplant Assoc. 1978;15:157–163. [PubMed] [Google Scholar]
  20. Ellis H. A., McCarthy J. H., Herrington J. Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation. J Clin Pathol. 1979 Aug;32(8):832–844. doi: 10.1136/jcp.32.8.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gacek E. M., Babb A. L., Uvelli D. A., Fry D. L., Scribner B. H. Dialysis dementia: the role of dialysate pH in altering the dialyzability of aluminum. Trans Am Soc Artif Intern Organs. 1979;25:409–415. [PubMed] [Google Scholar]
  22. Galle P., Chatel M., Berry J. P., Menault F. Encéphalopathie myoclonique progressive des dialysés: présence d'aluminium en forte concentration dans les lysosomes des cellules cérébrales. Nouv Presse Med. 1979 Dec 24;8(50):4091–4094. [PubMed] [Google Scholar]
  23. Geary D. F., Fennell R. S., Andriola M., Gudat J., Rodgers B. M., Richard G. A. Encephalopathy in children with chronic renal failure. J Pediatr. 1980 Jul;97(1):41–44. doi: 10.1016/s0022-3476(80)80127-2. [DOI] [PubMed] [Google Scholar]
  24. Gilli P., Bastiani P., Rosati G., Fiocchi O., Squerzanti R., Tataranni G., Farinelli A. Impairment of the mental status of patients on regular dialysis treatment. Proc Eur Dial Transplant Assoc. 1980;17:306–311. [PubMed] [Google Scholar]
  25. Graf H., Stummvoll H. K., Meisinger V., Kovarik J., Wolf A., Pinggera W. F. Aluminum removal by hemodialysis. Kidney Int. 1981 Apr;19(4):587–592. doi: 10.1038/ki.1981.56. [DOI] [PubMed] [Google Scholar]
  26. Hodsman A. B., Sherrard D. J., Wong E. G., Brickman A. S., Lee D. B., Alfrey A. C., Singer F. R., Norman A. W., Coburn J. W. Vitamin-D-resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism. Ann Intern Med. 1981 May;94(5):629–637. doi: 10.7326/0003-4819-94-5-629. [DOI] [PubMed] [Google Scholar]
  27. Jacobs C., Brunner F. P., Chantler C., Donckerwolcke R. A., Gurland H. J., Hathway R. A., Selwood N. H., Wing A. J. Combined report on regular dialysis and transplantation in Europe, VII, 1976. Proc Eur Dial Transplant Assoc. 1977;14:3–69. [PubMed] [Google Scholar]
  28. Kaehny W. D., Alfrey A. C., Holman R. E., Shorr W. J. Aluminum transfer during hemodialysis. Kidney Int. 1977 Nov;12(5):361–365. doi: 10.1038/ki.1977.123. [DOI] [PubMed] [Google Scholar]
  29. Kaehny W. D., Hegg A. P., Alfrey A. C. Gastrointestinal absorption of aluminum from aluminum-containing antacids. N Engl J Med. 1977 Jun 16;296(24):1389–1390. doi: 10.1056/NEJM197706162962407. [DOI] [PubMed] [Google Scholar]
  30. Kovalchik M. T., Kaehny W. D., Hegg A. P., Jackson J. T., Alfrey A. C. Aluminum kinetics during hemodialysis. J Lab Clin Med. 1978 Nov;92(5):712–720. [PubMed] [Google Scholar]
  31. Mahurkar S. D., Meyers L., Jr, Cohen J., Kamath R. V., Dunea G. Electroencephalographic and radionuclide studies in dialysis dementia. Kidney Int. 1978 Apr;13(4):306–315. doi: 10.1038/ki.1978.44. [DOI] [PubMed] [Google Scholar]
  32. Mahurkar S. D., Salta R., Smith E. C., Dhar S. K., Meyers L., Jr, Dunea G. Dialysis dementia. Lancet. 1973 Jun 23;1(7817):1412–1415. doi: 10.1016/s0140-6736(73)91740-6. [DOI] [PubMed] [Google Scholar]
  33. Mahurkar S. D., Smith E. C., Mamdani B. H., Dunea G. Dialysis dementia -- the Chicago experience. J Dial. 1978;2(5-6):447–458. doi: 10.3109/08860227809080098. [DOI] [PubMed] [Google Scholar]
  34. Marsden S. N., Parkinson I. S., Ward M. K., Ellis H. A., Kerr D. N. Evidence for aluminium accumulation in renal failure. Proc Eur Dial Transplant Assoc. 1979;16:588–596. [PubMed] [Google Scholar]
  35. Masramón J., Ricart M. J., Caralps A., Lloveras J., Andreu J., Brulles A., Solá R. Dialysis encephalopathy. Lancet. 1978 Jun 24;1(8078):1370–1370. doi: 10.1016/s0140-6736(78)92454-6. [DOI] [PubMed] [Google Scholar]
  36. McDermott J. R., Smith A. I., Ward M. K., Parkinson I. S., Kerr D. N. Brain-aluminium concentration in dialysis encephalopathy. Lancet. 1978 Apr 29;1(8070):901–904. doi: 10.1016/s0140-6736(78)90681-5. [DOI] [PubMed] [Google Scholar]
  37. Mehta R. P. Encephalopathy in chronic renal failure appearing before the start of dialysis. Can Med Assoc J. 1979 May 5;120(9):1112–1114. [PMC free article] [PubMed] [Google Scholar]
  38. Parkinson I. S., Beckett A., Ward M. K., Feest T. G., Hoenich N., Strong A., Kerr D. N. Aluminium: removal from water supplies. Proc Eur Dial Transplant Assoc. 1978;15:586–587. [PubMed] [Google Scholar]
  39. Parkinson I. S., Ward M. K., Feest T. G., Fawcett R. W., Kerr D. N. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet. 1979 Feb 24;1(8113):406–409. doi: 10.1016/s0140-6736(79)90883-3. [DOI] [PubMed] [Google Scholar]
  40. Pierides A. M., Edwards W. G., Jr, Cullum U. X., Jr, McCall J. T., Ellis H. A. Hemodialysis encephalopathy with osteomalacic fractures and muscle weakness. Kidney Int. 1980 Jul;18(1):115–124. doi: 10.1038/ki.1980.117. [DOI] [PubMed] [Google Scholar]
  41. Pierides A. M., Ward M. K., Kerr D. N. Letter: Haemodialysis encephalopathy: Possible role of phosphate depletion. Lancet. 1976 Jun 5;1(7971):1234–1235. doi: 10.1016/s0140-6736(76)92176-0. [DOI] [PubMed] [Google Scholar]
  42. Platts M. M., Anastassiades E. Dialysis encephalopathy: precipitating factors and improvement in prognosis. Clin Nephrol. 1981 May;15(5):223–228. [PubMed] [Google Scholar]
  43. Platts M. M., Goode G. C., Hislop J. S. Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. Br Med J. 1977 Sep 10;2(6088):657–660. doi: 10.1136/bmj.2.6088.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Platts M. M., Hislop J. S. Letter: Aluminium and dialysis encephalopathy. Lancet. 1976 Jul 10;2(7976):98–98. doi: 10.1016/s0140-6736(76)92315-1. [DOI] [PubMed] [Google Scholar]
  45. Poisson M., Mashaly R., Lebkiri B. Dialysis encephalopathy: recovery after interruption of aluminium intake. Br Med J. 1978 Dec 9;2(6152):1610–1611. doi: 10.1136/bmj.2.6152.1610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rozas V. V., Port F. K., Easterling R. E. An outbreak of dialysis dementia due to aluminum in the dialysate. J Dial. 1978;2(5-6):459–470. doi: 10.3109/08860227809080099. [DOI] [PubMed] [Google Scholar]
  47. Rozas V. V., Port F. K., Rutt W. M. Progressive dialysis encephalopathy from dialysate aluminum. Arch Intern Med. 1978 Sep;138(9):1375–1377. [PubMed] [Google Scholar]
  48. Rudolph H., Alfrey A. C., Smythe W. R. Muscle and serum trace element profile in uremia. Trans Am Soc Artif Intern Organs. 1973;19:456–465. doi: 10.1097/00002480-197301900-00079. [DOI] [PubMed] [Google Scholar]
  49. Rutherford E., King S., Perry B., Blondin J., Finley T., Mason N., Sparks R., Slatopolsky E. Use of a new phosphate binder in chronic renal insufficiency. Kidney Int. 1980 Apr;17(4):528–534. doi: 10.1038/ki.1980.61. [DOI] [PubMed] [Google Scholar]
  50. Short A. I., Winney R. J., Robson J. S. Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication. Proc Eur Dial Transplant Assoc. 1980;17:226–233. [PubMed] [Google Scholar]
  51. Smith D. B., Lewis J. A., Burks J. S., Alfrey A. C. Dialysis encephalopathy in peritoneal dialysis. JAMA. 1980 Jul 25;244(4):365–366. [PubMed] [Google Scholar]
  52. Sullivan P., Murnaghan D. J., Callaghan N. Dialysis dementia: recovery after transplantation. Br Med J. 1977 Sep 17;2(6089):740–740. doi: 10.1136/bmj.2.6089.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Tsukamoto Y., Iwanami S., Marumo F. Disturbances of trace element concentrations in plasma of patients with chronic renal failure. Nephron. 1980;26(4):174–179. doi: 10.1159/000181976. [DOI] [PubMed] [Google Scholar]
  54. Ward M. K., Feest T. G., Ellis H. A., Parkinson I. S., Kerr D. N. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium. Lancet. 1978 Apr 22;1(8069):841–845. doi: 10.1016/s0140-6736(78)90191-5. [DOI] [PubMed] [Google Scholar]
  55. Williams E. D., Elliott H. L., Boddy K., Haywood J. K., Henderson I. S., Harvey I., Kennedy A. C. Whole body aluminium in chronic renal failure and dialysis encephalopathy. Clin Nephrol. 1980 Oct;14(4):198–200. [PubMed] [Google Scholar]
  56. Zumkley H., Bertram H. P., Lison A., Knoll O., Losse H. Aluminum, zinc and copper concentrations in plasma in chronic renal insufficiency. Clin Nephrol. 1979 Jul;12(1):18–21. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES